CAPRICOR THERAPEUTICS, INC. (CAPR) Total liabilities 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) total liabilities at each fiscal year-end, per SEC filings.
$50.2MFY2025 · since FY2016: $22.8M → $50.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $50.2M | +100.5% |
| FY2024 | $25.0M | -30.8% |
| FY2023 | $36.1M | -5.7% |
| FY2022 | $38.3M | +284.5% |
| FY2021 | $10.0M | +55.2% |
| FY2020 | $6.4M | +50.2% |
| FY2019 | $4.3M | -7.7% |
| FY2018 | $4.6M | -8.2% |
| FY2017 | $5.0M | -77.8% |
| FY2016 | $22.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CAPR financial trends
CAPR RevenueCAPR Net incomeCAPR Net marginCAPR Gross profitCAPR Gross marginCAPR Operating incomeCAPR Operating marginCAPR Operating cash flowCAPR Free cash flowCAPR Capital expendituresCAPR Return on equityCAPR Stock buybacksCAPR Dividends paidCAPR Total assetsCAPR Shareholders’ equityCAPR overview →